The use of resistant potato starch (RPS), to modify gut microbial metabolism.
Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies
Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.